PHASE I DOSE‐ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR CHEMORESISTANT, RELAPSED/REFRACTORY, OR HIGH‐RISK NON‐HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS. (12th June 2019) - Maakaron, J.; Zhao, Q.; Puto, M.; Von Derau, R.; Robinson, J.; Brammer, J.; Penza, S.; Baiocchi, R.; Christian, B.; Maddocks, K.; Saad, A.; Wall, S.; et al.